(Q44593639)

English

FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast

scientific article published on 28 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ductal carcinoma

1 reference

based on heuristic

inferred from title

invasive cancer

1 reference

based on heuristic

inferred from title

4

object named as

Koei Chin

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Aseem Lal

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Loretta Chan

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sandy Devries

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Gary K Scott

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Christopher C Benz

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Yunn-Yi Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Frederic M Waldman

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

E Shelley Hwang

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

0 references

publication date

28 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

139

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

381-390

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

https://scigraph.springernature.com/pub.10.1007/s10549-013-2556-4

0 references

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Control of regulatory T cell lineage commitment and maintenance

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

FOXP3 defines regulatory T cells in human tumor and autoimmune disease

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Protein acetylation and histone deacetylase expression associated with malignant breast cancer progression

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

FOXP3 expression and overall survival in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Tamoxifen-stimulated growth of breast cancer due to p21 loss

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2556-4

21 January 2018

Identifiers

10.1007/S10549-013-2556-4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44593639&oldid=2028840670"